TB PAN-NET - Pan-European network for the study and clinical management of drug resistant tuberculosis / Edukad projektid

koordinaator-riik [ IT ] partner-riik [ DE ] otsingusõna [ Hain Lifescience GmbH ]

Pan-European network for the study and clinical management of drug resistant tuberculosis

akronüüm:	TB PAN-NET
algus:	2009-01-01
lõpp:	2013-12-31

programm:	FP7 - Euroopa Liidu 7. raamprogramm
alaprogramm:	HEALTH - Tervis
instrument:	CP-IP - Suuremahulised integreeritud projektid
projektikonkurss:	FP7-HEALTH-2007-B
projekti number:	223681
kestus kuudes:	60
partnerite arv:	27

lühikokkuvõte:	This proposal will establish an integrated and synergistic network to address the challenge of multiple drug resistant tuberculosis (MDR-TB) facing the EU. The objective will be attained through the establishment of a European consortium of expert partners with extensive experience in the conduct of basic and clinical research relating to MDR-TB, TB control and epidemiology. This Consortium will achieve this by: • Conducting an extensive and focused programme of basic/clinical research to improve the diagnosis and management of MDR-TB • Develop a broad training curriculum leading to the creation of a new generation of scientists and clinicians expert in the management of drug resistant TB • Create field sites across the EU with the capacity for evaluating new diagnostic systems and novel drug therapies on behalf of European industry and government • Establish a unified and robust quality assurance mechanism for the accurate and rapid diagnosis of drug resistance and develop appropriate safety standard for European health care workers • Improving our understanding of the transmission of MDR-TB at the molecular level and host-related risk factors for its development, • The Consortium will disseminate its findings and analyses widely to the benefit of specialists, general health care staff, EU governments, NGOs and health policy makers. This will provide researchers and clinicians with appropriate knowledge and improved tools to fight MDR-TB, and assist European industry in the development of new diagnostics and treatments. Consortium outputs will assist governments in the development and implementation of appropriate health and social policies to limit and control the spread of MDR-TB within the member states of the EU. Internationally, these objectives will assist countries bordering the EU and international agencies such as the WHO and ECDC in reducing the impact of drug resistance.

partneri jrk nr ja roll		partneri nimi	riik	kontaktisik	koduleht
1	koordinaator	UNIVERSITA VITA-SALUTE SAN RAFFAELE	IT	Raffaella Voltolini	http://www.unihsr.it
2	partner	QUEEN MARY AND WESTFIELD COLLEGE, UNIVERSITY OF LONDON	UK	Lindsey Warren	http://www.qmul.ac.uk
3	partner	FORSCHUNGSZENTRUM BORSTEL	DE	Susann Schrader	http://www.fz-borstel.de
4	partner	FONDAZIONE SALVATORE MAUGERI CLINICA DEL LAVORO E DELLA RIABILITAZIONE	IT	Gabriele Daniele	http://www.fsm.it
5	partner	AZIENDA OSPEDALIERA SAN GERARDO DI MONZA	IT	Deborah Ferro
6	partner	EUROPEAN RESPIRATORY SOCIETY	CH	Lucy Templeman	http://www.ersnet.org
7	partner	FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS	CH	Herbert Clemens
8	partner	SMITTSKYDDSINSTITUTET	SE	Anette Bäck	http://www.smittskyddsintitutet.se
9	partner	STATENS SERUM INSTITUT	DK	Håkon Lundamo	http://www.ssi.dk
10	partner	HRVATSKI ZAVOD ZA JAVNO ZDRAVSTVO	HR	Cendo Melita	http://www.hzjz.hr
11	partner	UNIVERSITA' DEGLI STUDI DI SIENA	IT	Silvano Focardi	http://www.unisi.it
12	partner	Hain Lifescience GmbH	DE	David Hain	http://www.hain-lifescience.de
13	partner	LATVIJAS INFEKTOLOGIJAS CENTRS (INFECTOLOGY CENTER OF LATVIA)	LV	Ineta Zirina	http://www.lic.gov.lv
14	partner	MONTESSORI GUIDO	IT	Guido Montessori
15	partner	Tartu Ülikooli Kliinikum SA	EE	Siigur Urmas	http://www.kliinikum.ee
16	partner	VIESOJI ISTAIGA VILNIAUS UNIVERSITETO LIGONINES SANTARISKIU KLINIKOS	LT	Aldona Kustova	http://www.santa.lt
17	partner	VILNIAUS UNIVERSITETAS	LT	Leonas Pasakarnis	http://www.vu.lt
18	partner	NASJONALT FOLKEHELSEINSTITUTT	NO	Terje Steffensen	http://www.fhi.no
19	partner	Bolnisnica Golnik Klinicni oddelek za pljucne bolezni in alergijo	SI	Lea Ulcnik
20	partner	PRINS LEOPOLD INSTITUUT VOOR TROPISCHE GENEESKUNDE	BE	Jef Van Lint	http://www.itg.be
21	partner	SPITALUL DE PNEUMOFTIZIOLOGIE BRASOV	RO	Claudiu Grusea
22	partner	INSTITUTUL DE PNEUMOFTIZIOLOGIE "MARIUS NASTA"	RO	Doinita Goicea	http://www.mariusnasta.ro
23	partner	INSTITUT PASTEUR DE LILLE FONDATION	FR	Fabienne Jean	http://www.pasteur-lille.fr
24	partner	TERVEYDEN JA HYVINVOINNIN LAITOS	FI	Jaakko Penttinen	http://www.thl.fi
25	partner	INSTITUT SCIENTIFIQUE DE SANTE PUBLIQUE	BE	Marc Van Pee	http://www.wiv-isp.be
26	partner	INSTYTUT GRUZLICY I CHOROB PLUC	PL	Jadwiga Leczycka	http://www.igichp.edu.pl
27	partner	University of Medicine and Dentistry of New Jersey	US	Alla Rabinovich